Influence of Medication on Fatigue Six Months after Stroke

Poststroke fatigue (PSF) is frequent and affects patients’ quality of life. Medication use was hypothesized as being responsible for PSF. Our objective was to evaluate potential relationships between 6-month PSF and medication use at discharge and 6 months after an ischemic stroke. This study is par...

Full description

Bibliographic Details
Main Authors: Amélie Ponchel, Julien Labreuche, Stéphanie Bombois, Christine Delmaire, Régis Bordet, Hilde Hénon
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:Stroke Research and Treatment
Online Access:http://dx.doi.org/10.1155/2016/2410921
id doaj-d2b55560ca244138b697e0f446189452
record_format Article
spelling doaj-d2b55560ca244138b697e0f4461894522021-07-02T02:02:45ZengHindawi LimitedStroke Research and Treatment2090-81052042-00562016-01-01201610.1155/2016/24109212410921Influence of Medication on Fatigue Six Months after StrokeAmélie Ponchel0Julien Labreuche1Stéphanie Bombois2Christine Delmaire3Régis Bordet4Hilde Hénon5Degenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, FranceDepartment of Statistics, EA 2694, Univ. Lille, 59000 Lille, FranceDegenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, FranceDegenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, FranceDegenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, FranceDegenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, FrancePoststroke fatigue (PSF) is frequent and affects patients’ quality of life. Medication use was hypothesized as being responsible for PSF. Our objective was to evaluate potential relationships between 6-month PSF and medication use at discharge and 6 months after an ischemic stroke. This study is part of STROKDEM, an ongoing longitudinal cohort study, whose main aim is to determine predictors of poststroke dementia. Patients were included within 72 hours after an ischemic stroke and followed up with standardized evaluations. Medication use 7 days and 6 months after stroke was rated, and polypharmacy was defined as the number of categories of treatments received by a patient. PSF was evaluated using the Chalder Fatigue Scale. Medical history, vascular risk factors, depression, anxiety, and sleep disturbances were evaluated. One hundred and fifty-three patients were included: 52.9% presented PSF. PSF at 6 months was not predicted by medication use at discharge nor associated with medication use at month 6. We found severity of PSF to be increased in patients with polypharmacy. Our results suggest that PSF is not a side effect of drugs use, which more reflects presence of disturbances frequently observed after stroke such as depression, anxiety, or sleep disturbances. Clinical study is registered on clinicaltrials.gov (NCT01330160).http://dx.doi.org/10.1155/2016/2410921
collection DOAJ
language English
format Article
sources DOAJ
author Amélie Ponchel
Julien Labreuche
Stéphanie Bombois
Christine Delmaire
Régis Bordet
Hilde Hénon
spellingShingle Amélie Ponchel
Julien Labreuche
Stéphanie Bombois
Christine Delmaire
Régis Bordet
Hilde Hénon
Influence of Medication on Fatigue Six Months after Stroke
Stroke Research and Treatment
author_facet Amélie Ponchel
Julien Labreuche
Stéphanie Bombois
Christine Delmaire
Régis Bordet
Hilde Hénon
author_sort Amélie Ponchel
title Influence of Medication on Fatigue Six Months after Stroke
title_short Influence of Medication on Fatigue Six Months after Stroke
title_full Influence of Medication on Fatigue Six Months after Stroke
title_fullStr Influence of Medication on Fatigue Six Months after Stroke
title_full_unstemmed Influence of Medication on Fatigue Six Months after Stroke
title_sort influence of medication on fatigue six months after stroke
publisher Hindawi Limited
series Stroke Research and Treatment
issn 2090-8105
2042-0056
publishDate 2016-01-01
description Poststroke fatigue (PSF) is frequent and affects patients’ quality of life. Medication use was hypothesized as being responsible for PSF. Our objective was to evaluate potential relationships between 6-month PSF and medication use at discharge and 6 months after an ischemic stroke. This study is part of STROKDEM, an ongoing longitudinal cohort study, whose main aim is to determine predictors of poststroke dementia. Patients were included within 72 hours after an ischemic stroke and followed up with standardized evaluations. Medication use 7 days and 6 months after stroke was rated, and polypharmacy was defined as the number of categories of treatments received by a patient. PSF was evaluated using the Chalder Fatigue Scale. Medical history, vascular risk factors, depression, anxiety, and sleep disturbances were evaluated. One hundred and fifty-three patients were included: 52.9% presented PSF. PSF at 6 months was not predicted by medication use at discharge nor associated with medication use at month 6. We found severity of PSF to be increased in patients with polypharmacy. Our results suggest that PSF is not a side effect of drugs use, which more reflects presence of disturbances frequently observed after stroke such as depression, anxiety, or sleep disturbances. Clinical study is registered on clinicaltrials.gov (NCT01330160).
url http://dx.doi.org/10.1155/2016/2410921
work_keys_str_mv AT amelieponchel influenceofmedicationonfatiguesixmonthsafterstroke
AT julienlabreuche influenceofmedicationonfatiguesixmonthsafterstroke
AT stephaniebombois influenceofmedicationonfatiguesixmonthsafterstroke
AT christinedelmaire influenceofmedicationonfatiguesixmonthsafterstroke
AT regisbordet influenceofmedicationonfatiguesixmonthsafterstroke
AT hildehenon influenceofmedicationonfatiguesixmonthsafterstroke
_version_ 1721343992849760256